Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial

Febe Smits, Kaz Groen, Mark-David Levin, Claudia A. M. Stege, Roel J. W. van Kampen, Ellen van der Spek, Yavuz M. Bilgin, Noortje Thielen, Inger S. Nijhof, Inge Ludwig, Esther G. M. De Waal, Yorick Sandberg, Alain Kentos, Gert Jan Timmers, Josien C. Regelink, Matthijs Westerman, Koen de Heer, Marie Christiane Vekemans, Nazik Durdu-Rayman, Nicole de GraauwMaarten R. Seefat, Niels W. C. J. van de Donk, Paula F. Ypma, Kazem Nasserinejad, Sonja Zweegman

Research output: Contribution to journalMeeting AbstractAcademicpeer-review

Original languageEnglish
Pages (from-to)4739-4740
Number of pages2
JournalBlood
Volume144
DOIs
Publication statusPublished - 5 Nov 2024

Cite this